跳至主要内容
临床试验/DRKS00026261
DRKS00026261已完成不适用

evaluation of atherosclerotic vascular lesions and terminal diseases as well as cardiovascular risk factors and experimental biomarkers in patients with primary sjögren-syndrome - Ath-pSS

Medizinische Hochschule Hannover in Kooperation mit der Else-Kröner-Fresenius-Stiftung0 个研究点目标入组 317 人开始时间: 2021年9月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
317

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Inclusion criteria for patient population:
  • - Age of majority (>18)
  • - ability to give informed consent is given
  • - confirmed diagnosis of primary Sjögren's syndrome (at least 2/3 criteria from the classification criteria for pSS of the American College of Rheumatology/European League Against Rheumatism 2016)
  • - At least 5 years cancer free survival
  • Inclusion criteria for control subjects:
  • - Age of majority (>18)
  • - Ability to give informed consent is given
  • (matched recruitment by age and sex to patient population).

排除标准

  • Exclusion criteria for pSS patients
  • - Active cancer or cancer that occurred less than five years ago.
  • - Incapable of giving informed consent
  • - not at the age of majority (>18 yrs.)
  • - Pregnancy
  • - Not fulfilling at least 2/3 classification criteria as defined by the American College of Rheumatology/European League Against Rheumatism of 2016.
  • - known arterial occlusive diseases (peripheral arterial occlusive disease, coronary heart disease, stroke, myocardial infarction)
  • Exclusion criteria for control subjects
  • - not at the age of majority (>18 yrs.)
  • - Incapable of giving informed consent
  • - Active cancer or cancer that occurred less than five years ago
  • - Pregnancy
  • - known arterial occlusive diseases (peripheral arterial occlusive disease, coronary heart disease)
  • - known underlying rheumatic/inflammatory diseases, especially vasculitides, rheumatoid arthritis or systemic lupus erythematosus

研究者

发起方
Medizinische Hochschule Hannover in Kooperation mit der Else-Kröner-Fresenius-Stiftung

相似试验